Can Fite (Israel) Backtesting

CANF -- Israel Stock  

ILS 234.30  1.30  0.56%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of Can Fite BioPharma Ltd and determine expected loss or profit from investing in Can Fite over given investment horizon. Check also Can Fite Hype Analysis, Can Fite Correlation, Can Fite Valuation, Can Fite Volatility as well as analyze Can Fite Alpha and Beta and Can Fite Performance.
Horizon     30 Days    Login   to change
SymbolX
Backtest

Can Fite 'What if' Analysis

September 17, 2018
0.00
No Change 0.00  0.0%
In 31 days
October 17, 2018
0.00
If you would invest  0.00  in Can Fite on September 17, 2018 and sell it all today you would earn a total of 0.00 from holding Can Fite BioPharma Ltd or generate 0.0% return on investment in Can Fite over 30 days. Can Fite is related to or competes with Bezeq Israel, Oil Refineries, Perrigo Company, Bank Leumi, Israel Chemicals, NICE Ltd, and Azrieli Group. Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for th...

Can Fite Upside/Downside Indicators

Information Ratio0.13
Maximum Drawdown6.14
Value At Risk3.16
Potential Upside1.93
  

Can Fite Market Premium Indicators

Risk Adjusted Performance0.18
Jensen Alpha0.36
Total Risk Alpha0.19
Treynor Ratio0.2943

Can Fite BioPharma Backtested Returns

Macroaxis considers Can Fite to be not too risky. Can Fite BioPharma secures Sharpe Ratio (or Efficiency) of -0.0212 which signifies that Can Fite BioPharma had -0.0212% of return per unit of risk over the last 1 month. Macroaxis philosophy towards foreseeing risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. Can Fite BioPharma Ltd exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Can Fite BioPharma Risk Adjusted Performance of 0.18 and Mean Deviation of 1.21 to double-check risk estimate we provide. Macroaxis gives Can Fite performance score of 0 on a scale of 0 to 100. The firm shows Beta (market volatility) of -0.9932 which signifies that . Even though it is essential to pay attention to Can Fite BioPharma historical returns, it is always good to be careful when utilizing equity current trending patterns. Macroaxis philosophy towards foreseeing future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Can Fite BioPharma Ltd exposes twenty-one different technical indicators which can help you to evaluate its performance. Can Fite BioPharma has expected return of -0.032%. Please be advised to confirm Can Fite BioPharma Standard Deviation, Information Ratio, Treynor Ratio, as well as the relationship between Variance and Jensen Alpha to decide if Can Fite BioPharma past performance will be repeated at some point in the near future.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation 0.33 

Below average predictability

Can Fite BioPharma Ltd has below average predictability. Overlapping area represents the amount of predictability between Can Fite time series from September 17, 2018 to October 2, 2018 and October 2, 2018 to October 17, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Can Fite BioPharma price movement. The serial correlation of 0.33 indicates that nearly 33.0% of current Can Fite price fluctuation can be explain by its past prices.
Correlation Coefficient0.33
Spearman Rank Test0.17
Residual Average0.0
Price Variance20.59

Can Fite BioPharma lagged returns against current returns

 Current and Lagged Values 
      Timeline 

Can Fite regressed lagged prices vs. current prices

 Current vs Lagged Prices 
      Timeline 

Can Fite Lagged Returns

 Regressed Prices 
      Timeline 

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Portfolio Rebalancing

Can Fite Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Can Fite and Bezeq The Israel. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Can Fite Hype Analysis, Can Fite Correlation, Can Fite Valuation, Can Fite Volatility as well as analyze Can Fite Alpha and Beta and Can Fite Performance. Please also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Search macroaxis.com